GGrantIndex
← Leaderboards

Roy E Weiss

University Of Chicago

$3,465,766
Attributed
$4,882,848
Total exposure
18
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.4M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$32,270,306 · 20

By mechanism

P50$17,340,403 · 3
U54$11,936,498 · 1
R01$1,293,399 · 1
M01$707,996 · 13
K24$515,300 · 1
T32$476,710 · 1

Most similar at University Of Chicago

Same institution · by research overlap

Others in their field

Top investigators on “Obesity

Research focus

ObesityInstitutionPreventHealth DisparityResourcesSocialCommunitiesDesignHypertensionResearch TrainingHealth ProfessionalFosteringGeneticClinical ResearchBiologicalDiabetes MellitusAsthmaMedicinePopulation HealthFacultyAfrican AmericanCollaborationsBehavioralCardiovascular Diseases

Grant awards (52)

Southeast Collaborative for Innovative Solutions to Chronic Diseases$3,460,805
P50 · FY2025 · MD
Community Team Lifestyle Immersion Program for Chronic Disease Prevention and Control$943,785
P50 · FY2025 · MD
Southeast Collaborative for Innovative and Equitable Solutions to Chronic Disease Disparities$2,454,140
P50 · FY2024 · MD
Southeast Collaborative for Innovative and Equitable Solutions to Chronic Disease Disparities$945,658
P50 · FY2024 · MD
Southeast Collaborative for Innovative and Equitable Solutions to Chronic Disease Disparities$945,658
P50 · FY2024 · MD
Southeast Collaborative for Innovative and Equitable Solutions to Chronic Disease Disparities$2,482,970
P50 · FY2023 · MD
Southeast Collaborative for Innovative and Equitable Solutions to Chronic Disease Disparities$813,481
P50 · FY2023 · MD
Southeast Collaborative for Innovative and Equitable Solutions to Chronic Disease Disparities$2,474,638
P50 · FY2022 · MD
Southeast Collaborative for Innovative and Equitable Solutions to Chronic Disease Disparities$319,066
P50 · FY2022 · MD
Southeast Collaborative for Innovative and Equitable Solutions to Chronic Disease Disparities$2,500,202
P50 · FY2021 · MD
Center of Excellence in Precision Medicine and Population Health$2,333,758
U54 · FY2020 · MD
Center of Excellence in Precision Medicine and Population Health$211,245
U54 · FY2020 · MD
Center of Excellence in Precision Medicine and Population Health$2,218,943
U54 · FY2019 · MD
Center of Excellence in Precision Medicine and Population Health$2,323,142
U54 · FY2018 · MD
Center of Excellence in Precision Medicine and Population Health$150,392
U54 · FY2018 · MD
Center of Excellence in Precision Medicine and Population Health$2,314,913
U54 · FY2017 · MD
Center of Excellence in Precision Medicine and Population Health$2,384,105
U54 · FY2016 · MD
Pediatric Endocrinology Research Training Grant$115,504
T32 · FY2013 · DK · contact PI
Pediatric Endocrinology Research Training Grant$86,606
T32 · FY2012 · DK · contact PI
Pediatric Endocrinology Research Training Grant$7,083
T32 · FY2012 · DK · contact PI
Pediatric Endocrinology Research Training Grant$122,237
T32 · FY2011 · DK · contact PI
Pediatric Endocrinology Research Training Grant$28,944
T32 · FY2011 · DK · contact PI
Pediatric Endocrinology Research Training Grant$116,336
T32 · FY2010 · DK · contact PI
Nuclear cofactors in Human Thyroid Disease$107,622
K24 · FY2007 · RR · contact PI
RESISTANCE TO THYROID HORMONE$13,474
M01 · FY2007 · RR · contact PI
STUDIES OF CUSHING'S DISEASE$10,670
M01 · FY2007 · RR · contact PI
Nuclear cofactors in Human Thyroid Disease$105,272
K24 · FY2006 · RR · contact PI
250 MICROGRAM ACTH STIMULATION TEST IN PREGNANCY$12,625
M01 · FY2006 · RR · contact PI
THE ROLE OF CORTISOL IN GESTATIONAL DIABETES MELLITUS$6,312
M01 · FY2006 · RR · contact PI
Thyroid Hormone Receptor Isoforms &Coactivators In Vivo$258,579
R01 · FY2005 · DK
RESISTANCE TO THYROID HORMONE$236,945
M01 · FY2005 · RR
Nuclear cofactors in Human Thyroid Disease$102,995
K24 · FY2005 · RR
THE EFFECTS OF RECOMBINANT HUMAN TSH IN NON-TSH RTSH$73,766
M01 · FY2005 · RR
250 MICROGRAM ACTH STIMULATION TEST IN PREGNANCY$45,451
M01 · FY2005 · RR
HORMONAL EVALUATION CUSHING'S SYNDROME$35,765
M01 · FY2005 · RR
THE ROLE OF CORTISOL IN GESTATIONAL DIABETES MELLITUS$12,668
M01 · FY2005 · RR
CUSHINGS DISEASE AND PPAR-G ANGONISTS$8,941
M01 · FY2005 · RR
Thyroid Hormone Receptor Isoforms &Coactivators In Vivo$257,965
R01 · FY2004 · DK
Cushings disease and PPAR-g agonists$119,456
M01 · FY2004 · RR
Nuclear cofactors in Human Thyroid Disease$100,779
K24 · FY2004 · RR
Hormonal Evaluation Cushing's Syndrome$66,365
M01 · FY2004 · RR
Thyroid Hormone Receptor Isoforms &Coactivators In Vivo$258,046
R01 · FY2003 · DK
Nuclear cofactors in Human Thyroid Disease$98,632
K24 · FY2003 · RR
Thyroid Hormone Receptor Isoforms &Coactivators In Vivo$257,600
R01 · FY2002 · DK
ACTH &CORTISOL RESPONSE TO DEXAMETHASONE IN MORBIDLY OBESE ADULTS$0
M01 · FY2002 · RR
HORMONAL EVALUATION OF CUSHINGS SYNDROME &NON ACTH SECRETING PITUITARY TUMORS$0
M01 · FY2002 · RR
Thyroid Hormone Receptor Isoforms &Coactivators In Vivo$261,209
R01 · FY2001 · DK
ACTH &CORTISOL RESPONSE TO DEXAMETHASONE IN MORBIDLY OBESE ADULTS$32,779
M01 · FY2000 · RR
ACTH STIMULATION TEST TO EVALUATE ADEQUACY OF HPA AXIS$32,779
M01 · FY2000 · RR
HORMONAL EVALUATION OF CUSHINGS SYNDROME &NON ACTH SECRETING PITUITARY TUMORS$0
M01 · FY2000 · RR
ACTH &CORTISOL RESPONSE TO DEXAMETHASONE IN MORBIDLY OBESE ADULTS$0
M01 · FY2000 · RR
HORMONAL EVALUATION OF CUSHINGS SYNDROME &NON ACTH SECRETING PITUITARY TUMORS$0
M01 · FY2000 · RR